RCAG
PBYI icon

Rehmann Capital Advisory Group’s Puma Biotechnology PBYI Stock Holding History

Rehmann Capital Advisory Group’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$871 Hold
81
– – ﹤0.01% 1579
2019
Q2 		$1.03K Hold
81
– – ﹤0.01% 1922
2019
Q1 		$3.14K Hold
81
– – ﹤0.01% 1642
2018
Q4 		$1.65K Hold
81
– – ﹤0.01% 1516
2018
Q3 		$3.71K Sell
81
-6
-7% -$289 ﹤0.01% 1634
2018
Q2 		$5.15K Buy
87
+6
+7% +$348 ﹤0.01% 1537
2018
Q1 		$6K Buy
+81
New +$6.07K ﹤0.01% 1469

Other funds holding PBYI

PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return